Operating Income (Loss) of VitaNova Life Sciences Corp from 31 Oct 2017 to 31 Oct 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
VitaNova Life Sciences Corp quarterly and annual Operating Income (Loss) in USD history and change rate from 31 Oct 2017 to 31 Oct 2025.
  • VitaNova Life Sciences Corp Operating Income (Loss) for the quarter ending 31 Oct 2025 was $99,170, a 58% increase year-over-year.
  • VitaNova Life Sciences Corp Operating Income (Loss) for the twelve months ending 31 Oct 2025 was $1,257,858, a 392% increase year-over-year.
  • VitaNova Life Sciences Corp annual Operating Income (Loss) for 2024 was $1,208,314, a 488% increase from 2023.
  • VitaNova Life Sciences Corp annual Operating Income (Loss) for 2023 was $205,629.
  • VitaNova Life Sciences Corp annual Operating Income (Loss) for 2022 was $24,227, a 81% decline from 2021.
Source SEC data
View on sec.gov
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

VitaNova Life Sciences Corp Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,257,858 $99,170 +$36,570 +58% 01 Aug 2025 31 Oct 2025 10-Q 15 Dec 2025 2026 Q2
Q2 2025 $1,221,288 $32,440 +$12,974 +29% 01 May 2025 31 Jul 2025 10-Q 12 Sep 2025 2026 Q1
Q1 2025 $1,208,314 $1,082,254 +$849,571 +365% 01 Feb 2025 30 Apr 2025 10-K 24 Jul 2025 2025 FY
Q4 2024 $358,743 $108,874 +$102,926 +1730% 01 Nov 2024 31 Jan 2025 10-Q 17 Mar 2025 2025 Q3
Q3 2024 $255,817 $62,600 +$71,355 01 Aug 2024 31 Oct 2024 10-Q 15 Dec 2025 2026 Q2
Q2 2024 $184,462 $45,414 -$21,167 -87% 01 May 2024 31 Jul 2024 10-Q 12 Sep 2025 2026 Q1
Q1 2024 $205,629 $232,683 01 Feb 2024 30 Apr 2024 10-K 24 Jul 2025 2025 FY
Q4 2023 $5,948 01 Nov 2023 31 Jan 2024 10-Q 17 Mar 2025 2025 Q3
Q3 2023 $8,755 01 Aug 2023 31 Oct 2023 10-Q 13 Dec 2024 2025 Q2
Q2 2023 $24,247 -$26,381 -1236% 01 May 2023 31 Jul 2023 10-Q 14 Sep 2023 2024 Q1
Q2 2022 $2,134 +$12,620 01 May 2022 31 Jul 2022 10-Q 14 Sep 2023 2024 Q1
Q3 2021 $68,939 $29,991 -$17,606 -142% 01 Aug 2021 31 Oct 2021 10-Q 10 Nov 2021 2021 Q2
Q2 2021 $51,333 $10,486 +$761 +6.8% 01 May 2021 31 Jul 2021 10-Q 01 Sep 2022 2022 Q1
Q1 2021 $52,094 $25,563 +$774 +2.9% 01 Feb 2021 30 Apr 2021 10-K 16 May 2022 2022 FY
Q4 2020 $52,868 $2,899 +$3,695 +56% 01 Nov 2020 31 Jan 2021 10-Q 21 Jun 2021 2021 Q3
Q3 2020 $56,563 $12,385 +$7,134 +37% 01 Aug 2020 31 Oct 2020 10-Q 10 Nov 2021 2021 Q2
Q2 2020 $63,697 $11,247 +$8,637 +43% 01 May 2020 31 Jul 2020 10-Q 20 Aug 2021 2022 Q1
Q1 2020 $72,334 $26,337 -$15,108 -135% 01 Feb 2020 30 Apr 2020 10-K 01 Jul 2021 2021 FY
Q4 2019 $57,226 $6,594 +$30,102 +82% 01 Nov 2019 31 Jan 2020 10-Q 21 Jun 2021 2021 Q3
Q3 2019 $87,328 $19,519 -$11,459 -142% 01 Aug 2019 31 Oct 2019 10-Q 25 Nov 2020 2021 Q2
Q2 2019 $75,869 $19,884 -$4,058 -26% 01 May 2019 31 Jul 2019 10-Q 18 Sep 2020 2021 Q1
Q1 2019 $71,811 $11,229 01 Feb 2019 30 Apr 2019 10-K 05 Aug 2020 2020 FY
Q4 2018 $36,696 01 Nov 2018 31 Jan 2019 10-Q 20 Mar 2020 2020 Q3
Q3 2018 $8,060 -$13,840 -239% 01 Aug 2018 31 Oct 2018 10-Q 06 Dec 2019 2020 Q2
Q2 2018 $15,826 01 May 2018 31 Jul 2018 10-Q 12 Sep 2019 2020 Q1
Q3 2017 $5,780 01 Aug 2017 31 Oct 2017 10-Q 18 Dec 2018 2019 Q2

VitaNova Life Sciences Corp Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,208,314 +$1,002,685 +488% 01 May 2024 30 Apr 2025 10-K 24 Jul 2025 2025 FY
2023 $205,629 +$229,856 01 May 2023 30 Apr 2024 10-K 24 Jul 2025 2025 FY
2022 $24,227 -$10,860 -81% 01 May 2022 30 Apr 2023 10-K 29 Jul 2024 2024 FY
2021 $13,367 +$38,727 +74% 01 May 2021 30 Apr 2022 10-K 15 May 2023 2023 FY
2020 $52,094 +$20,240 +28% 01 May 2020 30 Apr 2021 10-K 16 May 2022 2022 FY
2019 $72,334 -$523 -0.73% 01 May 2019 30 Apr 2020 10-K 01 Jul 2021 2021 FY
2018 $71,811 -$23,162 -48% 01 May 2018 30 Apr 2019 10-K 05 Aug 2020 2020 FY
2017 $48,649 01 May 2017 30 Apr 2018 10-K 30 Jul 2019 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.